Total Tumor Volume on18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with225 Ac-PSMA-I&T

by Albert, N.L, Bartenstein, P., Beyer, L., Brendel, M., Casuscelli, J., Cyran, C.C, Gildehaus, F.J, Herlemann, A., Holzgreve, A., Ilhan, H., Kunte, S.C, Kunz, W.G, Ricke, J., Schmidt-Hegemann, N.-S, Sheikh, G.T, Stief, C.G, Todica, A., Unterrainer, L.M, Unterrainer, M., Wenter, V., Zacherl, M.J
Published 2022